MOVEMENT DISORDERS

Self-administration of the drug led to statistically significant motor status changes within 30 minutes of treatment.
Expert panelists provide advice to neurologists to incorporate the use of botulinum toxic injections into their practice to treat sialorrhea in PD.

SAP Partner Banner

About NeurologyLive's Movement Disorders Clinical Focus page:

The NeurologyLive Movement Disorder Clinical Focus center provides a source of up-to-date clinical information, with articles covering updates from the robust pipeline of novel therapies, and the newest data from all phases of clinical trials and studies in the space. It also serves as a hub of information and news from the upcoming and ongoing conferences and annual meetings hosted by neurological societies and associations on the latest advances in Parkinson disease, Tardive dyskinesia, Huntington disease, and more. 
 
This resource includes a wealth of interviews with movement disorder specialists, and moderated Peer Exchange discussions about the best practices and key methods for treating complex cases, utilizing the newest therapies, examining the issues and challenges of treatment options, and much more.